Ocrelizumab reduces cortical and deep grey matter loss compared to the S1P-receptor modulator in multiple sclerosis Albulena BajramiAgnese TamantiMassimiliano Calabrese Original Communication Open access 30 January 2024 Pages: 2149 - 2158
Isolated cognitive impairment in people with multiple sclerosis: frequency, MRI patterns and its development over time Piet M. BoumanMaureen A. van DamHanneke E. Hulst Original Communication Open access 30 January 2024 Pages: 2159 - 2168
Male sexual and reproductive health in multiple sclerosis: a scoping review Karlo ToljanFarren B. S. Briggs Review Open access 28 February 2024 Pages: 2169 - 2181
The role of ethnicity and native-country income in multiple sclerosis: the Italian multicentre study (MS-MigIT) Alessia BianchiDomenica Matrangathe the MS-MigIT Study Group Original Communication Open access 16 February 2024 Pages: 2182 - 2194
Identifying and understanding cognitive profiles in multiple sclerosis: a role for visuospatial memory functioning Maureen van DamEva A. KrijnenHanneke E. Hulst Original Communication Open access 26 February 2024 Pages: 2195 - 2206
A randomized controlled trial of oral antipyretic treatment to reduce overheating during exercise in adults with multiple sclerosis Victoria M. LeavittCeren TozluKaho Onomichi Original Communication 28 February 2024 Pages: 2207 - 2215
Risk of secondary progression in patients with highly active multiple sclerosis treated with natalizumab: a real-life study Louisa SchererMarc SoudantGuillaume Mathey Original Communication 29 February 2024 Pages: 2216 - 2224
Infratentorial posterior reversible encephalopathy syndrome in INFβ1a-treated multiple sclerosis patient Gianni CutilloMartina RubinMassimo Filippi Letter to the Editors 22 February 2024 Pages: 2225 - 2229
Endovascular thrombectomy for DAWN- and DEFUSE-3 ineligible acute ischemic stroke patients: a systematic review and meta-analysis Samah MorsiSherief GhozyDavid F. Kallmes Review 03 February 2024 Pages: 2230 - 2237
Potential of neuroimaging as a biomarker in amyotrophic lateral sclerosis: from structure to metabolism Wei SunSi-Han LiuXue-Fan Yu Review 17 February 2024 Pages: 2238 - 2257
Artificial intelligence in neurology: opportunities, challenges, and policy implications Sebastian VoigtlaenderJohannes PawelczykSebastian F. Winter Review 17 February 2024 Pages: 2258 - 2273
Risk of intracranial hemorrhage in brain arteriovenous malformations: a systematic review and meta-analysis Bryan Gervais de LiyisAnak Agung Istri Kosalya AriniIsmail Setyopranoto Review 24 February 2024 Pages: 2274 - 2284
Retinal imaging for the assessment of stroke risk: a systematic review Zain GirachArni SarianThomas H. Julian Review Open access 02 March 2024 Pages: 2285 - 2297
The efficacy and safety of FcRn inhibitors in patients with myasthenia gravis: a systematic review and meta-analysis Jiaxuan LiXin WuZhong Wang Review 03 March 2024 Pages: 2298 - 2308
Tenecteplase versus alteplase for acute ischemic stroke: a systematic review and meta-analysis of randomized and non-randomized studies Yu MaHunong XiangXin Sun Review 04 March 2024 Pages: 2309 - 2323
Multiple system atrophy: an update and emerging directions of biomarkers and clinical trials Min LiuZhiyao WangHuifang Shang Review Open access 14 March 2024 Pages: 2324 - 2344
Genetics of ischemic stroke functional outcome Troy P. CarnwathStacie L. DemelCharles J. Prestigiacomo Review Open access 19 March 2024 Pages: 2345 - 2369
Radiologically isolated syndromes: to treat or not to treat? Paolo PreziosaMaria A. RoccaMassimo Filippi Review 19 March 2024 Pages: 2370 - 2378
Efficacy and safety of selumetinib in patients with neurofibromatosis type 1 and inoperable plexiform neurofibromas: a systematic review and meta-analysis Yahui HanBiyun LiJiao Zhang Review 19 March 2024 Pages: 2379 - 2389
Health-related quality of life across disease stages in patients with amyotrophic lateral sclerosis: results from a real-world survey Katie StensonT. E. FecteauS. Parvanta Original Communication Open access 11 January 2024 Pages: 2390 - 2404
Thrombolysis in Stroke-Heart Syndrome: a useful tool for neurocardiac wellness? Ilario ScaliMarcello NaccaratoPaolo Manganotti Original Communication 11 January 2024 Pages: 2405 - 2411
Prognosis of impulse control disorders in Parkinson’s disease: a prospective controlled study Thomas WirthThibaut GoetschMathieu Anheim Original Communication 12 January 2024 Pages: 2412 - 2422
Prevalence, clinical characteristics, and risk factors of intracerebral haemorrhage in CADASIL: a case series and systematic review Nontapat SukhonpanichHugh S. Markus Original Communication Open access 13 January 2024 Pages: 2423 - 2433
Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study Piero BarbantiCinzia AuriliaERT; for the Italian Migraine Registry study group Original Communication Open access 17 January 2024 Pages: 2434 - 2443
Correction to: Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study Piero BarbantiCinzia Auriliafor the Italian Migraine Registry study group Correction Open access 02 April 2024 Pages: 2444 - 2445
Etiologic distribution of dizziness/vertigo in a neurological outpatient clinic according to the criteria of the international classification of vestibular disorders: a single-center study Yue XingLihong SiXu Yang Original Communication Open access 17 January 2024 Pages: 2446 - 2457
Serum calcitonin gene-related peptide in patients with persistent post-concussion symptoms, including headache: a cohort study Peter Preben EggertsenJohan PalmfeldtJørgen Feldbæk Nielsen Original Communication Open access 17 January 2024 Pages: 2458 - 2472
Real-world evidence of epidemiology, patient characteristics, and mortality in people with drug-resistant epilepsy in the United Kingdom, 2011–2021 Rohit ShankarXiaocong Li MarstonLara Groves Original Communication Open access 19 January 2024 Pages: 2473 - 2483
Identifying the mediating role of inflammation on the relationship between socioeconomic status and Alzheimer’s disease: a Mendelian randomization analysis and mediation analysis Chaofan GengKe MengYi Tang Original Communication 22 January 2024 Pages: 2484 - 2493
Neuropathy in ARSACS is demyelinating but without typical nerve enlargement in nerve ultrasound Katharina KneerStephanie StraubAlexander Grimm Original Communication Open access 23 January 2024 Pages: 2494 - 2502
Utility of genetic testing in the pre-surgical evaluation of children with drug-resistant epilepsy Sarah AlsubhiSaoussen BerrahmouneKenneth A. Myers Original Communication 23 January 2024 Pages: 2503 - 2508
Longitudinal volumetric changes in amygdala subregions in frontotemporal dementia Mengjie HuangRamon Landin-RomeroOlivier Piguet Original Communication Open access 24 January 2024 Pages: 2509 - 2520
Free water imaging in Parkinson’s disease and atypical parkinsonian disorders Apurva ShahShweta PrasadMadhura Ingalhalikar Original Communication 24 January 2024 Pages: 2521 - 2528
Association of grip strength and walking pace with the risk of incident Parkinson’s disease: a prospective cohort study of 422,531 participants Kai-Min WuKevin KuoJin-Tai Yu Original Communication 24 January 2024 Pages: 2529 - 2538
Abnormal vestibular-evoked myogenic potentials as a risk factor for unpredicted falls in spinocerebellar ataxia: a preliminary study Seo-Young ChoiKwang-Dong ChoiJi-Soo Kim Original Communication Open access 27 January 2024 Pages: 2539 - 2546
Mismatch between clinically defined classification of ALS stage and the burden of cerebral pathology Pedram ParnianpourMichael BenatarSanjay Kalra Original Communication 28 January 2024 Pages: 2547 - 2559
Reduced eye gaze fixation during emotion recognition among patients with temporal lobe epilepsy Kailing HuangZiwei TianLi Feng Original Communication 30 January 2024 Pages: 2560 - 2572
Progression rate of radiation-induced carotid stenosis in head and neck cancer survivors after statin treatment: a retrospective cohort study Yanting ChenYongteng XuYamei Tang Original Communication 08 February 2024 Pages: 2573 - 2581
The impact of subthalamic deep-brain stimulation in restoring motor symmetry in Parkinson’s disease patients: a prospective study Raquel Pinheiro BarbosaCaroline Moreauthe PREDISTIM Group Original Communication 09 February 2024 Pages: 2582 - 2595
Hippocampal sclerosis is associated with celiac disease type immunity in patients with drug-resistant temporal lobe epilepsy Maria PeltolaKatri KaukinenJukka Peltola Original Communication Open access 10 February 2024 Pages: 2596 - 2604
Impact of multiple treatment cycles with anti-CGRP monoclonal antibodies on migraine course: focus on discontinuation periods. Insights from the multicenter, prospective, I-GRAINE study Piero BarbantiCinzia Auriliafor the Italian Migraine Registry (I-GRAINE) study group Original Communication Open access 12 February 2024 Pages: 2605 - 2614
Assessing the synergistic effectiveness of intermittent theta burst stimulation and the vestibular ocular reflex rehabilitation protocol in the treatment of Mal de Debarquement Syndrome: a randomised controlled trial Cherylea J. BrowneS. R. SheebaR. Cavaleri Original Communication Open access 12 February 2024 Pages: 2615 - 2630
Cerebral microbleeds and risk of symptomatic hemorrhagic transformation following mechanical thrombectomy for large vessel ischemic stroke Rémi AgbononGéraud ForestierGrégoire Boulouis Original Communication 14 February 2024 Pages: 2631 - 2638
The comorbidity profiles and medication issues of patients with multiple system atrophy: a systematic cross-sectional analysis Lan YeStephan GretenMartin Klietz Original Communication Open access 14 February 2024 Pages: 2639 - 2648
Risdiplam improves subjective swallowing quality in non-ambulatory adult patients with 5q-spinal muscular atrophy despite advanced motor impairment S. BrakemeierJ. LipkaT. Hagenacker Original Communication Open access 15 February 2024 Pages: 2649 - 2657
Characterizing coma in large vessel occlusion stroke Michael J. YoungAmine AwadRobert W. Regenhardt Original Communication 16 February 2024 Pages: 2658 - 2661
Patterns and utility of myelin oligodendrocyte glycoprotein (MOG) antibody testing in cerebrospinal fluid Jodie M. BurtonSaerom YounFiona Costello Original Communication 16 February 2024 Pages: 2662 - 2671
Genome-wide DNA methylation analysis related to ALS patient progression and survival Tianmi YangChunyu LiHuifang Shang Original Communication 19 February 2024 Pages: 2672 - 2683
Effectiveness of endovascular treatment for in-hospital stroke vs. community-onset stroke: a propensity score-matched analysis Jae Wook JungKwang Hyun Kimon behalf of the SECRET Study Group Original Communication 20 February 2024 Pages: 2684 - 2693
A Delphi consensus to identify the key screening tests/questions for a digital neurological examination for epidemiological research Vasco Ribeiro FerreiraCarol BrayneValentina Gallo Original Communication Open access 20 February 2024 Pages: 2694 - 2703
